The role of a dihydromorphanthridine derivative in Parkinson's patients treated with L-dopa. A preliminary report.
D000978:Antiparkinson Agents / Q000008:administration & dosage* / Q000627:therapeutic use; D003984:Dibenzazepines / Q000008:administration & dosage* / Q000627:therapeutic use; D004295:Dihydroxyphenylalanine / Q000008:administration & dosage* / Q000009:adverse effects / Q000627:therapeutic use; D004123:Dimethylamines / Q000008:administration & dosage / Q000627:therapeutic use; D004357:Drug Synergism; D005069:Evaluation Studies as Topic; D006801:Humans; D009127:Muscle Rigidity / Q000188:drug therapy; D010300:Parkinson Disease / Q000188:drug therapy*; D014202:Tremor / Q000188:drug therapy*
D000978:Antiparkinson Agents; D003984:Dibenzazepines; D004123:Dimethylamines; D004295:Dihydroxyphenylalanine